Search Results

Mahendran Jayaraj, MD

Dr. Jayaraj is a fellowship-trained and board-certified gastroenterologist with the Orlando Health Digestive Health Institute. He specializes in the diagnosis and treatment of patients with diseases affecting the esophagus, stomach, intestines, and other digestive organs.

In The News Dr. Sreeram Maddipatla

For colon cancer and many other forms of the disease, clinical trials offer patients treatment beyond the standard of care.

New Blood Cancer Drug May Benefit Patients Who Don’t Respond to Chemotherapy

From immunotherapy and surgery to chemotherapy, we’ve made several advancements in cancer treatment.

Proton Therapy Q&A with Dr. Naren Ramakrishna

In 2012, our team broke ground on a very special endeavor at the Orlando Health Cancer Institute. One that will surge our Cancer Center forward as providers of the latest and most effective technologies in healthcare and, more importantly, serve the community by giving our patients the best possible chance to win their fight against cancer.

A Study Testing the Combo of Dasatinib or Imatinib to Chemo Treatment W/ Blinatumomab for Children, Adolescents, & YA W/ Ph+ or Ph-Like B-cell B-ALL

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Orlando Health Arnold Palmer Hospital for Children and Orlando Health Winnie Palmer Hospital for Women & Babies Achieves Magnet® Designation

Learn about the achievements of Orlando Health Arnold Palmer Hospital for Children and Orlando Health Winnie Palmer Hospital for Women & Babies.

Alexandra Heidtmann Nobre, DPM

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma